Landmark China trial gets 84% efficacy in treating cancer with clue from waste water tech

Nano-carbon iron injection halts tumour growth in 16 patients, induces shrinkage in two, with Phase II trial now under way with 52 others.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.